User: Guest  Login
Title:

Final Analysis of a Phase I/IIa Study With CV9103, an Intradermally Administered Prostate Cancer Immunotherapy Based on Self Adjuvanted mRNA

Document type:
Meeting Abstract
Author(s):
Kubler, H; Stenzl, A; Schultze-Seemann, W; Dorp, FV; Pilla, L; Hampel, C; Jocham, D; Development, C; Miller, K
Journal title abbreviation:
Eur J Cancer
Year:
2011
Journal volume:
47 1
Pages contribution:
S498-S499
Language:
eng
Print-ISSN:
0959-8049
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX